Vitamin C infusions have become a common part of breast cancer treatment - with benefits claimed by some patients. But its use has also been controversial due to a lack of clinical evidence around its effectiveness.
Now a new study aims to end the debate.
Led by Otago University vitamin C expert Professor Margreet Vissers, who featured in a documentary by TVNZ's Sunday last year, the project will determine the vitamin's ability to slow the growth and spread of cancer.
The $84,000 study will see Professor Vissers' team analyse breast cancer tumour tissue from the Christchurch tissue bank - an essential first step before progressing to clinical trials which require a sound rationale for enlisting patients.
Similar analysis have been conducted by Visser with bowel cancer and endometrial cancer tissue and the findings revealed patients with higher levels of vitamin C in their tumours have extended disease-free survival.